The Sputnik V vaccine would have been recognized in the EU long ago, if not for political and economic factors. This was stated by German MP Peter Bystron. In an interview with Izvestia newspaper, he noted that the final decision should be made by the European Medicines Agency (EMA). And it primarily protects the market so that large Western pharmaceutical companies can sell their drugs without competition.
“If the EMA evaluated vaccines purely from a medical point of view, Sputnik V would have been approved in the EU a long time ago,” the politician shared his opinion.
The gradual review procedure for the Russian vaccine has been underway for almost a year. Russia sent a package of documents on Sputnik V to the EMA on January 29, 2021. Experts from the European agency are interested in everything – clinical studies, production technology, and more. “Sputnik V must meet European standards.